In 2026, an estimated 67,530 people will be diagnosed with pancreatic cancer, according to the American Cancer Society. But ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

Scientists in Spain say they have uncovered a cure for pancreatic cancer in mice. The breakthrough could help people ...

Catching pancreatic cancer early is among the most difficult challenges faced by medical providers, and that delay often ends ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical ...

The biochemist’s company, Vega Oncotargets, has toned down its message after the false expectations generated by the ...

A team of researchers at the Georgetown University Lombardi Comprehensive Cancer Center published new research exploring causes and potential treatment methods for pancreatic ...

The scientists found that KLF5 had the greatest effect specifically promoting the growth and invasion of metastatic cells, ...

Researchers in Spain have developed a therapy protocol that could revolutionize the treatment of pancreatic cancer.

Cancer researchers say they are cautiously optimistic after Spanish scientists reported eliminating pancreatic tumors in mice ...

Notoriously tricky to detect, pancreatic cancer also often resists traditional therapy. So, researchers are urgently looking for new ways to disrupt tumor formation. Though scientists know that the ...

On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...